DK3171873T3 - Sammensætning omfattende en ester af alfa-tocopherol til forebyggelse og behandling af allergisk rhinitis - Google Patents

Sammensætning omfattende en ester af alfa-tocopherol til forebyggelse og behandling af allergisk rhinitis Download PDF

Info

Publication number
DK3171873T3
DK3171873T3 DK15720286.2T DK15720286T DK3171873T3 DK 3171873 T3 DK3171873 T3 DK 3171873T3 DK 15720286 T DK15720286 T DK 15720286T DK 3171873 T3 DK3171873 T3 DK 3171873T3
Authority
DK
Denmark
Prior art keywords
alpha
prevention
treatment
composition
allergic rhinitis
Prior art date
Application number
DK15720286.2T
Other languages
English (en)
Inventor
Jürgen Lamprecht
Giorgio Panin
Original Assignee
Bio Lo Ga Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51589387&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3171873(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Lo Ga Srl filed Critical Bio Lo Ga Srl
Application granted granted Critical
Publication of DK3171873T3 publication Critical patent/DK3171873T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK15720286.2T 2014-07-22 2015-04-17 Sammensætning omfattende en ester af alfa-tocopherol til forebyggelse og behandling af allergisk rhinitis DK3171873T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20141332 2014-07-22
PCT/EP2015/058368 WO2016012110A1 (en) 2014-07-22 2015-04-17 Composition comprising an ester of alpha-tocopherol for prevention and treatment of allergic rhinitis

Publications (1)

Publication Number Publication Date
DK3171873T3 true DK3171873T3 (da) 2020-03-16

Family

ID=51589387

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15720286.2T DK3171873T3 (da) 2014-07-22 2015-04-17 Sammensætning omfattende en ester af alfa-tocopherol til forebyggelse og behandling af allergisk rhinitis

Country Status (24)

Country Link
US (1) US20170165226A1 (da)
EP (1) EP3171873B1 (da)
CN (1) CN106659709A (da)
AR (1) AR101274A1 (da)
AU (1) AU2015294663B2 (da)
BR (1) BR112017001116A8 (da)
CA (1) CA2955664C (da)
CL (1) CL2017000058A1 (da)
CO (1) CO2017000550A2 (da)
CY (1) CY1122823T1 (da)
DE (1) DE202014106007U1 (da)
DK (1) DK3171873T3 (da)
EA (1) EA201692486A1 (da)
ES (1) ES2779525T3 (da)
HR (1) HRP20200380T1 (da)
HU (1) HUE049588T2 (da)
LT (1) LT3171873T (da)
MX (1) MX369991B (da)
PE (1) PE20170437A1 (da)
PL (1) PL3171873T3 (da)
PT (1) PT3171873T (da)
RS (1) RS60103B1 (da)
SI (1) SI3171873T1 (da)
WO (1) WO2016012110A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017214497A1 (en) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Non-comedogenic hair and scalp care formulations and method for use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4269835A (en) * 1979-12-13 1981-05-26 Whittle Barry J Nasal composition for relieving nasal distress
US4364945A (en) 1979-12-13 1982-12-21 Whittle Barry J Nasal composition for relieving nasal distress
US20100055152A1 (en) * 2008-08-26 2010-03-04 Trutek Corporation Antihistamine and antihistamine-like nasal application, products, and method
DE4327089A1 (de) 1993-08-12 1995-02-16 Roshdy Ismail Mittel zur Behandlung von allergischen Erkrankungen der Atemwege
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
ITMI981586A1 (it) * 1998-07-10 2000-01-10 Giorgio Panin Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
JP2003128552A (ja) 2001-08-16 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
US20060198904A1 (en) 2002-11-20 2006-09-07 Istvan Boldogh Methods for inhibiting allergic inflammation and other responses initiated by pollens, molds, and other non-animal derived allergens
JP2008266255A (ja) * 2007-04-24 2008-11-06 Project M:Kk アレルギー性疾患を予防および／または治療するための組成物
US20100076072A1 (en) 2008-07-25 2010-03-25 Northwestern University Compositions and methods of vitamin e administration
IT1393056B1 (it) * 2008-09-22 2012-04-11 Bio Lo Ga Srl Uso di vitamina e o suoi derivati per il controllo di artropodi
ITMI20090480A1 (it) * 2009-03-27 2010-09-28 Bio Lo Ga Srl Supporto tessile imbevuto di una composizione detergente/idratante
AU2012272652B2 (en) * 2011-06-24 2017-06-01 Epitogenesis Inc. Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators

Also Published As

Publication number Publication date
CL2017000058A1 (es) 2017-08-11
CO2017000550A2 (es) 2017-03-31
DE202014106007U1 (de) 2015-07-23
AU2015294663B2 (en) 2019-11-21
CY1122823T1 (el) 2021-05-05
ES2779525T3 (es) 2020-08-18
BR112017001116A8 (pt) 2022-07-05
PE20170437A1 (es) 2017-04-22
SI3171873T1 (sl) 2020-07-31
CA2955664A1 (en) 2016-01-28
US20170165226A1 (en) 2017-06-15
AU2015294663A1 (en) 2017-01-19
EP3171873B1 (en) 2019-12-25
EP3171873A1 (en) 2017-05-31
PL3171873T3 (pl) 2020-07-13
PT3171873T (pt) 2020-02-25
WO2016012110A1 (en) 2016-01-28
CN106659709A (zh) 2017-05-10
HRP20200380T1 (hr) 2020-08-07
HUE049588T2 (hu) 2020-10-28
EA201692486A1 (ru) 2017-07-31
CA2955664C (en) 2022-09-06
BR112017001116A2 (pt) 2018-01-23
LT3171873T (lt) 2020-04-10
RS60103B1 (sr) 2020-05-29
MX2017000906A (es) 2017-05-12
AR101274A1 (es) 2016-12-07
MX369991B (es) 2019-11-27

Similar Documents

Publication Publication Date Title
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3119797T3 (da) Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
DK3212778T3 (da) Fremgangsmåder og sammensætninger til stabilisering af trans-splejsning af intein-modificerede proteaser
DK3212226T3 (da) Sammensætninger og anvendelsesfremgangsmåder til behandling af metaboliske lidelser
DK3149019T3 (da) Cholan-derivater til anvendelse ved behandling og/eller forebyggelse af FXR- og TGR5/GPBAR1-formidlede sygdomme
DK3227675T3 (da) Activin-actrii-antagonister og anvendelser til behandling af myelodysplastisk syndrom
DK3277270T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
DK3189074T3 (da) Sammensætninger og metoder til behandling og forebyggelse af inflammation
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
DK3102555T3 (da) Sammensætninger af forbindelser og anvendelser deraf
DK3209696T3 (da) Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom
DK3204497T3 (da) Terapeutisk hæmning af lactatdehydrogenase og midler dertil
DK3157534T3 (da) Acetylcholinesterasehæmmere til behandling af dermatologiske tilstande
DK3081263T3 (da) Sammensætninger og redskaber til behandling af glaukom
DK3200748T3 (da) Sammensætninger og fremgangsmåder til behandling og profylakse af infektioner på operationssted
DK3142664T3 (da) Sammensætninger og fremgangsmåder til behandling og diagnosticering af øjensygdomme
DK3310190T3 (da) Sammensætning til behandling af kød og anvendelse af denne
DK3191103T3 (da) Sammensætninger og fremgangsmåder til behandling af præcancerøse hudlæsioner
DK3288379T3 (da) Peptidsammensætninger og anvendelsesmåder
DK2961420T3 (da) Fremgangsmåder og sammensætninger til forebyggelsen eller behandlingen af barth syndrom
DK3240821T3 (da) Lavdosis gashydrathæmmersammensætning og tilhørende fremgangsmåde
DK3522873T3 (da) Sammensætninger og fremgangsmåder til behandlingen af xerostomi
DK3122743T3 (da) Sammensætninger og fremgangsmåder til behandling af neurodegenerative sygdomme